Facing a vaccine crisis, Canada desperately needs a med-tech industrial strategy

Favourable procurement policies, additional funding, and private-public partnerships can build a Canadian health-care-industrial complex to allow Canadian companies to lead the world, create jobs, save and improve lives, and protect and enhance our Canadian economic and industrial interests.

For Canadian health-care companies to succeed, the provinces must centralize their procurement to favour Canadian health-care companies with a 'Buy Canadian' policy while the federal government provides extensive financing to help these companies to flourish. Also, Canada should encourage public-private partnerships in health-care innovation and business, writes Daniel Tsai.

Opinion

BY DANIEL TSAI

March 1, 2021

TORONTO—As the European Union threatens export controls on COVID-19 vaccine manufacturers for failing to meet their contracts and to adequately supply its EU citizens, and without COVID-19 vaccine manufacturing facilities of its own, Canada is helplessly at the mercy of others to supply our people...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy